Sodium bicarbonate therapy for patients with severe metabolic acidaemia in the intensive care unit (BICAR-ICU): A multicentre, open-label, randomised controlled, phase 3 trial.
Open accessThe DOI matches its Crossref record; 30 of the 30 references it cites were found in a registry or an index.
Abstract
Background Acute acidaemia is frequently observed during critical illness. Sodium bicarbonate infusion for the treatment of severe metabolic acidaemia is a possible treatment option but remains controversial, as no studies to date have examined its effect on clinical outcomes. Therefore, we aimed to evaluate whether sodium bicarbonate infusion would improve these outcomes in critically ill patients. Methods We did a multicentre, open-label, randomised controlled, phase 3 trial. Local investigators screened eligible patients from 26 intensive care units (ICUs) in France. We included adult patients (aged ≥18 years) who were admitted within 48 h to the ICU with severe acidaemia (pH ≤7·20, PaCO 2 ≤45 mm Hg, and sodium bicarbonate concentration ≤20 mmol/L) and with a total Sequential Organ Failure Assessment score of 4 or more or an arterial lactate concentration of 2 mmol/L or more. We randomly assigned patients (1:1), by stratified randomisation with minimisation via a restricted web platform, to receive either no sodium bicarbonate (control group) or 4·2% of intravenous sodium bicarbonate infusion (bicarbonate group) to maintain the arterial pH above 7·30. Our protocol recommended that the volume of each infusion should be within the range of 125-250 mL in 30 min, with a maximum of 1000 mL within 24 h after inclusion. Randomisation criteria were stratified among three prespecified strata: age, sepsis status, and the Acute Kidney Injury Network (AKIN) score. The primary outcome…
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“A patient-level meta-analysis showed no benefit of higher PEEP in all patients with ARDS; however, patients with moderate or severe ARDS (PaO 2 /FiO 2 ≤ 200 mm Hg) had decreased mortality with the use of higher PEEP, whereas those with mild ARDS did not (443).”
From Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock 2021. (2021) · cites this paper as [443]
In the citing paper
“In the subgroup of patients with AKI defined as AKI Network (AKIN) stage 2 or 3 at randomisation (182/389–47%), lower mortality was observed with bicarbonate therapy: control 57/90 (63%), bicarbonate (42/92–46%), absolute risk reduction (ARR) −17.7% (−33.0 to −2.3), p = 0.016.”
From Surviving sepsis campaign: international guidelines for management of sepsis and septic shock 2021 (2021) · cites this paper as [528]
In the citing paper
“No between-group difference was observed in the primary outcome of a composite of 28-day mortality and organ failure at day 7.”
From Surviving sepsis campaign: international guidelines for management of sepsis and septic shock 2021 (2021) · cites this paper as [528]
In the citing paper
“Sepsis was present in 61% (238/389) of patients at the time of randomisation.”
From Surviving sepsis campaign: international guidelines for management of sepsis and septic shock 2021 (2021) · cites this paper as [528]
In the citing paper
“No differential effect was observed between patients with vs without sepsis.”
From Surviving sepsis campaign: international guidelines for management of sepsis and septic shock 2021 (2021) · cites this paper as [528]
2 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
Vincent, J. L., Moreno, R., Takala, J., Willatts, S., De Mendonça, A., Bruining, H., Reinhart, C. K., Suter, P. M., & Thijs, L. G. (1996) · Intensive Care Medicine · doi:10.1007/bf01709751 · Cited by 11,674
Le Gall, J.-R. (1993) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.270.24.2957 · Cited by 7,773
The Surviving Sepsis Campaign Guidelines Committee including The Pediatric Subgroup*, Dellinger, R. P., Levy, M. M., Rhodes, A., Annane, D., Gerlach, H., Opal, S. M., Sevransky, J. E., Sprung, C. L., Douglas, I. S., et al. (2013) · Intensive Care Medicine · doi:10.1007/s00134-012-2769-8 · Cited by 7,290
Surviving Sepsis Campaign: International guidelines for management of sepsis and septic shock: 2016.
Rhodes, A., Evans, L. E., Alhazzani, W., Levy, M. M., Antonelli, M., Ferrer, R., Kumar, A., Sevransky, J. E., Sprung, C. L., Nunnally, M. E., et al. (2017) · Intensive Care Medicine · doi:10.1007/s00134-017-4683-6 · Cited by 6,621
Initiation strategies for renal-replacement therapy in the intensive care unit.
Gaudry, S., Hajage, D., Schortgen, F., Martin-Lefevre, L., Pons, B., Boulet, E., Boyer, A., Chevrel, G., Lerolle, N., Carpentier, D., et al. (2016) · New England Journal of Medicine · doi:10.1056/nejmoa1603017 · Cited by 1,243
Zarbock, A., Kellum, J. A., Schmidt, C., Van Aken, H., Wempe, C., Pavenstädt, H., Boanta, A., Gerß, J., & Meersch, M. (2016) · JAMA · doi:10.1001/jama.2016.5828 · Cited by 1,143
Adjunctive glucocorticoid therapy in patients with septic shock.
Venkatesh, B., Finfer, S., Cohen, J., Rajbhandari, D., Arabi, Y., Bellomo, R., Billot, L., Correa, M., Glass, P., Harward, M., et al. (2018) · New England Journal of Medicine · doi:10.1056/nejmoa1705835 · Cited by 1,037
Kraut, J. A., & Madias, N. E. (2014) · New England Journal of Medicine · doi:10.1056/nejmra1309483 · Cited by 850
(2012) · Kidney International Supplements · doi:10.1038/kisup.2011.32 · Cited by 757
Vinsonneau, C., Camus, C., Combes, A., Costa de Beauregard, M. A., Klouche, K., Boulain, T., Pallot, J.-L., Chiche, J.-D., Taupin, P., Landais, P., et al. (2006) · The Lancet · doi:10.1016/s0140-6736(06)69111-3 · Cited by 685
Self-citation
Cited by
Surviving sepsis campaign: international guidelines for management of sepsis and septic shock 2021
Evans, L., Rhodes, A., Alhazzani, W., Antonelli, M., Coopersmith, C. M., French, C., Machado, F. R., Mcintyre, L., Ostermann, M., Prescott, H. C., et al. (2021) · Intensive Care Medicine · doi:10.1007/s00134-021-06506-y · Cited by 5,082
Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock 2021.
Evans, L., Rhodes, A., Alhazzani, W., Antonelli, M., Coopersmith, C. M., French, C., Machado, F. R., Mcintyre, L., Ostermann, M., Prescott, H. C., et al. (2021) · Critical Care Medicine · doi:10.1097/ccm.0000000000005337 · Cited by 2,935
Ronco, C., Bellomo, R., & Kellum, J. A. (2019) · The Lancet · doi:10.1016/s0140-6736(19)32563-2 · Cited by 1,910
Zarbock, A., Nadim, M. K., Pickkers, P., Gomez, H., Bell, S., Joannidis, M., Kashani, K., Koyner, J. L., Pannu, N., Meersch, M., et al. (2023) · Nature Reviews Nephrology · doi:10.1038/s41581-023-00683-3 · Cited by 767
Nadim, M. K., Forni, L. G., Mehta, R. L., Connor, M. J., Liu, K. D., Ostermann, M., Rimmelé, T., Zarbock, A., Bell, S., Bihorac, A., et al. (2020) · Nature Reviews Nephrology · doi:10.1038/s41581-020-00356-5 · Cited by 690
Metadata
- Authors
- Jaber, S., Paugam, C., Futier, E., Lefrant, J.-Y., Lasocki, S., Lescot, T., Pottecher, J., Demoule, A., Ferrandière, M., Asehnoune, K., Dellamonica, J., Velly, L., Abback, P.-S., de Jong, A., Brunot, V., Belafia, F., Roquilly, A., Chanques, G., Muller, L., Constantin, J.-M., Bertet, H., Klouche, K., Molinari, N., Jung, B., Jaber, S., de Jong, A., Belafia, F., Chanques, G., Monnin, M., Delay, J.-M., Cissé, M., Geniez, M., Conseil, M., Souche, B., Paugam, C., Abback, P.-S., Futier, E., Constantin, J. M., Lefrant, J.-Y., Muller, L., Lasocki, S., Lescot, T., Pottecher, J., Noll, E., Demoule, A., Morawiec, E., Ferrandière, M., Asehnoune, K., Roquilly, A., Dellamonica, J., Robert, A., Velly, L., Triglia, T., Brunot, V., Molinari, N., Mechati, M., Arnal, J.-M., Durand-Gasselin, J., Demoly, D., Hraiech, S., Papazian, L., Gilles, V., Rimmelé, T., Riu, B., Cougot, P., Fourcade, O., Seguin, P., Charbit, J., Capdevila, X., Leone, M., Zieleskiewicz, L., Ichai, C., Orban, J. C., Darmon, M., Azoulay, E., Lemiale, V., Zafrani, L., Debbat, K., Mimoz, O., Guérin, C., & Kipnis, E.
- Affiliations
- Centre National de la Recherche Scientifique (FR)
- Inserm (FR)
- Université de Montpellier (FR)
- Assistance Publique – Hôpitaux de Paris (FR)
- Centre Hospitalier Universitaire de Nantes (FR)
- ORCID
- Venue
- The Lancet
- Publisher
- Elsevier BV
- Published
- 2018-07
- Volume
- 392
- Issue
- 10141
- Pages
- 31-40
- ISSN
- 0099-5355 (ISSN-L)
- 0140-6736
- OpenAlex
- W2807966166
- Semantic Scholar
- dc4574d33a320388d6beea18f186a642436f2801
- Cited by
- 410
- References
- 30
- Citations by year
- 2026: 64 · 2025: 60 · 2024: 40 · 2023: 49 · 2022: 43 · 2021: 46 · 2020: 41 · 2019: 51 · 2018: 15
- FWCI
- 31.32
- Type
- journal article
- Language
- en
- Update notices
- erratum (2018-12-08)
- Open access
- green
- hal.umontpellier.fr
- Licence
- other-oa
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- www.elsevier.com/legal/tdmrep-license (tdm)
- Locations
- The Lancet (publishedVersion)
- PubMed (publishedVersion)
- HAL (submittedVersion, other-oa)
- HAL (submittedVersion)
- Funders
- ResMed
- Topics
- Health Sciences › Medicine › Nephrology › Renal function and acid-base balance
- Health Sciences › Medicine › Critical Care and Intensive Care Medicine › Sepsis Diagnosis and Treatment
- Health Sciences › Medicine › Nephrology › Acute Kidney Injury Research
- Keywords
- sodium bicarbonate, critically ill patients, intensive care, acid-base balance, 28-day mortality, organ failure, sepsis, acute kidney injury, lactate, sodium bicarbonate infusion, subgroup analysis, prognostic model
- MeSH terms
- Acidosis, Humans, Hydrogen-Ion Concentration, Infusions, Intravenous, Intensive Care Units, Cohort Studies, Survival Analysis, Renal Replacement Therapy, Sodium Bicarbonate
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Sodium bicarbonate therapy for patients with severe metabolic acidaemia in the intensive care unit (BICAR-ICU): A multicentre, open-label, randomised controlled, phase 3 trial. https://app.cochat.ai/papers/10.1016/s0140-6736(18)31080-8
- The paper
- Jaber, S., Paugam, C., Futier, E., Lefrant, J.-Y., Lasocki, S., Lescot, T., Pottecher, J., Demoule, A., Ferrandière, M., Asehnoune, K., Dellamonica, J., Velly, L., Abback, P.-S., de Jong, A., Brunot, V., Belafia, F., Roquilly, A., Chanques, G., Muller, L., . . . Kipnis, E. (2018). Sodium bicarbonate therapy for patients with severe metabolic acidaemia in the intensive care unit (BICAR-ICU): A multicentre, open-label, randomised controlled, phase 3 trial. The Lancet. https://doi.org/10.1016/s0140-6736(18)31080-8
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.